Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Maxim Group Starts Super Micro Computer (SMCI) at Buy
-
Perseon (PRSN) Pricing of $5.2M Offering of Common Stock, Warrants
-
Perseon Announces Pricing of $5.2 Million Public Offering and Listing of Warrants on NASDAQ
-
Streetinsider.com's Hot Lunchtime Reads 7/27: (TEVA) (OII) (F) (RJET)
-
Teva Pharma (TEVA) PT Raised to $74 at Maxim Group on Deal for Allergan's Generic Drug Business
-
Magnet Media Adds to Growing Team with Four New Hires; Highlights Growth of Video Distribution Services
-
Trovagene, Inc. Announces Closing of Public Offering of Common Stock
-
Media Analyst John Tinker to Join G.research, LLC
-
Wheeler Real Estate Investment Trust, Inc. Announces Final Tender Results of Exchange Offer for Series A Preferred Stock and Series B Convertible Preferred Stock
-
United Health Products Engages Maxim Group LLC as Corporate Finance Advisor
-
Trovagene (TROV) Prices 4M Common Stock Offering for Proceeds of $35M
-
Trovagene, Inc. Announces Pricing of Public Offering of Common Stock
-
Maxim Group LLC Expands Equity Research With the Appointment of a Senior Restaurant & Consumer Analyst
-
Notable Analyst Rating Changes 7/15: (GES) (CSX) (LNKD) Upgraded; (LLY) (LPLA) (CINF) Downgraded
-
Pre-Open Stock Movers 07/15: (RCPT) (CELG) (GES) Higher; (ATI) (CBAY) (MJN) Lower (more...)
-
Amarantus Completes Acquisition of ESS From Lonza for the Treatment of Severe Burns
-
Amarantus Completes Acquisition of ESS From Lonza for the Treatment of Severe Burns
-
After-Hours Stock Movers 07/14: (RCPT) (CLSN) (CSX) Higher; (ATI) (CBAY) (MJN) Lower (more...)
-
Maxim Group Starts Celsion Corp (CLSN) at Buy
-
PlacementTracker Publishes First Half 2015 PIPE Market League Tables
-
Pre-Open Stock Movers 07/08: (GBSN) (TCS) (WWE) Higher; (SINA) (CLF) (TSLA) Lower (more...)
-
BioCorRx, Inc. Announces Engagement of Maxim Group LLC to Provide Strategic Advisory Services
-
After-Hours Stock Movers 07/07: (TCS) (TREE) (VMW) Higher; (CLVS) (KTWO) Lower (more...)
-
Maxim Group Starts Coffee Holding Co. (JVA) at Buy and Price Target of $7
-
Maxim Group Starts Guess (GES) at Buy
-
Provectus Biopharma (PVCT) Enters LOI with Boehringer Ingelheim to Bring PV-10 into China
-
Provectus Biopharmaceuticals Signs Letter of Intent with Boehringer Ingelheim (China) to Collaborate in Bringing PV-10 to Market in China
-
Maxim Group Starts Remark Media (MARK) at Buy
-
Notable Analyst Rating Changes 6/26: (GTLS) (LPNT) (HCA) Upgraded; (ARP) (FEYE) (ARMH) Downgraded
-
Maxim Group Starts Oculus Innovative Sciences (OCLS) at Buy
-
Pluristem Therapeutics (PSTI) Prices 6.8M Common Stock, Warrants Direct Offering at $2.50/Unit
-
Pluristem Therapeutics Announces Pricing of Registered Direct Offering of Common Stock and Warrants
-
Pluristem Therapeutics Announces Pricing of Registered Direct Offering of Common Stock and Warrants
-
Provectus Biopharmaceuticals, Inc. Announces Closing of Public Offering
-
Maxim Group Starts The WhiteWave Foods Company (WWAV) at Buy
-
Maxim Group Downgrades Radius Health (RDUS) to Hold
-
Rock Creek Pharmaceuticals Announces Closing of Registered Direct Offering
-
Provectus Biopharma (PVCT) Prices 17.5M Common, Warrants Offering at 75c/Unit
-
Provectus Biopharmaceuticals, Inc. Announces Pricing of Public Offering to Raise $13.1 Million
-
Provectus Biopharma (PVCT) to Offer Common Stock and Warrants
-
Provectus Biopharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants
-
Oxford Lane Capital Corp. Prices Preferred Stock Offering
-
Maxim Group Downgrades Lumenis (LMNS) to Hold
-
Notable Analyst Rating Changes 6/18: (JNPR) (HOG) (AMC) Upgraded; (RATE) (LUV) (NMBL) Downgraded
-
Pre-Open Stock Movers 06/18: (LMNS) (DGLY) (BMRN) Higher; (HERO) (RATE) (ORCL) Lower (more...)
-
Oxford Lane Capital Corp. Announces Preferred Stock Offering
-
After-Hours Stock Movers 06/17: (PIR) (BMRN) (JUNO) Higher; (RATE) (ONVO) (ORCL) Lower (more...)
-
Maxim Group Starts Kite Pharma (KITE) at Buy
-
Maxim Group Starts Juno Therapeutics (JUNO) at Buy
-
BioCardia (BCDA) Files $57.5M Common Stock IPO

